Efficient nickel-catalysed<i>N</i>-alkylation of amines with alcohols
作者:Anastasiia Afanasenko、Saravanakumar Elangovan、Marc C. A. Stuart、Giuseppe Bonura、Francesco Frusteri、Katalin Barta
DOI:10.1039/c8cy01200h
日期:——
selective N-alkylation of amines with alcohols, that is in situ generated from Ni(COD)2 and KOH under ligand-free conditions. This novel method is very efficient for the functionalization of aniline and derivatives with a wide range of aromatic and aliphatic alcohols as well as diols and exhibits excellent functionalgroup tolerance including halides, benzodioxane and heteroaromatic groups. Several TEM measurements
[EN] SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS<br/>[FR] SULFONAMIDES SUBSTITUÉS UTILES COMME INHIBITEURS DE BCL ANTI-APOPTOTIQUES
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012162365A1
公开(公告)日:2012-11-29
Disclosed are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: W and Q and G are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bcl-2 family antiapoptotic proteins for the treatment of cancer; and pharmaceutical compositions comprising such compounds.
Nickel‐Catalyzed Amination of Silyloxyarenes through C–O Bond Activation
作者:Eric M. Wiensch、John Montgomery
DOI:10.1002/anie.201806790
日期:2018.8.20
Silyloxyarenes were utilized as electrophilic coupling partners with amines in the synthesis of aniline derivatives. A diverse range of amine substrates were used, including cyclic or acyclic secondary amines, secondary anilines, and stericallyhindered primary anilines. Additionally, a range of stericallyhindered and unhindered primary aliphatic amines were employed, which have previously been challenging with
SUBSTITUTED SULFONAMIDES USEFUL AS ANTIAPOPTOTIC BCL INHIBITORS
申请人:Borzilleri Robert M.
公开号:US20140135318A1
公开(公告)日:2014-05-15
Disclosed are compounds of Formula (I), or a pharmaceutically acceptable salt thereof, wherein: W and Q and G are defined herein. Also disclosed are methods of using such compounds as inhibitors of Bcl-2 family antiapoptotic proteins for the treatment of cancer; and pharmaceutical compositions comprising such compounds.
A simple and efficient catalyst-free chemoselective reductive amination of primary amines and aldehydes to synthesis of tertiary and secondaryamines with borane complex was developed. Primary amines are converted into tertiary and secondaryamines in one pot reaction under mild condition with good functional group compatibility and It does not require any catalyst to participate in this reaction.